Diseases, Conditions, Syndromes

Pfizer says COVID-19 vaccine is looking 90% effective

Pfizer Inc. said Monday that its COVID-19 vaccine may be a remarkable 90% effective, based on early and incomplete test results that nevertheless brought a big burst of optimism to a world desperate for the means to finally ...

Diseases, Conditions, Syndromes

Pfizer reports encouraging, very early vaccine test results

The first of four experimental COVID-19 vaccines being tested by Pfizer and its German partner BioNTech showed encouraging results in very early testing of 45 people, the companies said Wednesday.

Other

EU greenlights GSK-Pfizer joint venture

The EU on Wednesday approved the merger of the consumer healthcare activities of pharmaceutical giants GlaxoSmithKline and Pfizer that produce over-the-counter medicines.

Medical economics

Pfizer to buy Array BioPharma in deal worth $11.4 billion

Pfizer is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma, a drug developer that has seen its shares soar since announcing positive clinical trial results earlier this spring.

Medical economics

GSK, Pfizer to merge consumer healthcare units

Pharmaceutical giants GlaxoSmithKline and Pfizer on Wednesday announced a merger of their consumer healthcare units that produce over-the-counter medicines.

page 26 from 40